Hosted on MSN7m
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.05 per share a year ago. These figures are ...
Hosted on MSN51mOpinion
New Strong Buy Stocks for January 8th
List today: Sony Group Corporation SONY: This electronic equipment company has seen the Zacks Consensus Estimate for its ...